This new generic medicine is designed to be a simple, once-daily treatment for children as young as three months old who ...

The FDA has granted approval for the ANDA of Lupin’s Sacubitril and Valsartan Tablets for heart failure patients.

Mumbai: Global pharma major Lupin Limited has announced that it has received approval from the United States Food and Drug ...

Lupin receives US FDA approval for sacubitril and valsartan tablets: Our Bureau, Mumbai Friday, January 24, 2025, 15:30 Hrs [IST] Global pharma major Lupin Limited (Lupin) announc ...

Lupin receives US FDA marketing nod for generic Triumeq PD tablets for oral suspension to trteat HIV-1 infection: Our Bureau, Mumbai Friday, January 24, 2025, 14:15 Hrs [IST] Glob ...

Today’s stock recommendations feature a mix of picks from the pharmaceutical, insurance, and chemicals sectors.

The US healthcare system under Trump 2.0 are likely to benefit Indian players, except for the push for increased US drug ...

Reuters Nifty continues to climb a wall of worry as it looks to be in the final leg of its rally before heading for a ...

In 2024, the Hatch-Waxman Act continued to play a critical role in the U.S. pharmaceutical landscape, driving the dynamics between ...

The Food and Drug Administration has given Lupin a tentative nod for two new generics. The first medication is loteprednol etabonate ophthalmic gel, 0.38%, which is a generic of Bausch & Lomb’s ...

The brokerage foresees strong performances from Lupin, Torrent, Ipca and Apollo Hospital, while Aurobindo and Max Healthcare may show more muted results.